Insights into Direct-Acting Antivirals

Insights Into Direct-Acting Antivirals: Mechanistic Impact on Chronic Hepatitis C is a comprehensive reference that explores Chronic Hepatitis C management. This authoritative reference covers the mechanisms, efficacy, and future potential of Direct-Acting Antivirals (DAAs), offering valuable insights for clinicians, researchers, and students in hepatology and infectious diseases. Structured into three sections, this reference covers a wide range of topics related to DAAs in the management of Hepatitis C. In Section 1, readers will gain a thorough understanding of HCV infection, its clinical significance, and the immune response involved. They will also explore the molecular mechanisms of DAAs and the different classes available. Section 2 focuses on the practical aspects of using DAAs in the treatment of HCV. Readers will discover the clinical efficacy of different DAA regimens, the safety and tolerability considerations, and the additional benefits of DAA treatment beyond virological response. The section also covers current treatment guidelines and individualized approaches for specific patient populations. In Section 3, readers will learn the challenges and future directions in DAA therapy including antiviral resistance in HCV and strategies for managing and overcoming resistance. The book also explores the relationship between DAA therapy and hepatocellular carcinoma, as well as the current limitations and unmet needs in DAA therapy. "Insights Into Direct-Acting Antivirals: Mechanistic Impact on Chronic Hepatitis C" is a comprehensive and indispensable resource for anyone involved in the management of Chronic Hepatitis C. With its in-depth exploration of DAAs, from their molecular mechanisms to their clinical applications and future directions, this book equips clinicians, researchers, and students with the knowledge and insights needed to enhance their practices and contribute to the global fight against HCV infection.

• Provides the latest scientific analyses and discussions on Direct-Acting Antivirals (DAAs) for hepatitis C virus (HCV) treatment to explain the molecular mechanisms, therapeutic effectiveness, and advancements in CHC management
• Includes insights from leading experts in hepatology, virology, pharmacology, and immunology for comprehensive view of current HCV research and therapy, emerging strategies, and technologies
• Shares strategic insights to optimize DAA therapy to overcome challenges like resistance development, managing specific patient populations, and combining DAAs with other treatments